Skip to main content
Erschienen in: Annals of Surgical Oncology 10/2010

01.10.2010 | Hepatobiliary Tumors

Predictors of Extrahepatic Recurrence After Curative Hepatectomy for Hepatocellular Carcinoma

verfasst von: Akinobu Taketomi, MD, PhD, Takeo Toshima, MD, Dai Kitagawa, MD, PhD, Takashi Motomura, MD, Kazuki Takeishi, MD, Yohei Mano, MD, Hiroto Kayashima, MD, Keishi Sugimachi, MD, PhD, Shinichi Aishima, MD, PhD, Yoichi Yamashita, MD, PhD, Toru Ikegami, MD, PhD, Tomonobu Gion, MD, PhD, Hideaki Uchiyama, MD, PhD, Yuji Soejima, MD, PhD, Takashi Maeda, MD, PhD, Ken Shirabe, MD, PhD, Yoshihiko Maehara, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this study was to elucidate the predictors of extrahepatic hepatocellular carcinoma (HCC) recurrence after hepatectomy.

Materials and Methods

A cohort of 252 patients with HCC who underwent hepatectomy following a recurrence were reviewed. The patients were categorized into 2 groups according to the pattern of their initial recurrence. Clinicopathological and survival data were compared between the groups.

Results

Of the 252 patients, 218 had intrahepatic recurrence (IHR) (86.5%) and 34 had extrahepatic recurrence (EHR) (13.5%) as their initial recurrence. The mean duration of time until the initial recurrence after hepatectomy of the EHR and IHR groups was 1.8 and 2.2 years, respectively. The rate of recurrence within 6 months after hepatectomy of EHR and IHR groups was 35.3 and 14.2%, respectively (P = .002). The 3-, 5-, and 10-year cumulative survival rates of EHR group were 60.3, 24.0, and 6.0%, respectively, which were significantly lower than that of IHR group (74.5, 57.7, and 23.1%, P = .004). A multivariate analysis showed that blood loss during surgery and microscopic hepatic vein invasion remained as independent risk factors for increased EHR after hepatectomy for HCC. Furthermore, the combination of these 2 independent factors showed a significant association with the EHR.

Conclusions

EHR of HCC was associated with early recurrence and a poor survival after a hepatectomy. The combination of 2 independent factors for EHR, the presence of microscopic hepatic vein invasion and the blood loss during surgery, may be useful for predicting the risk for occurrence of EHR during the follow-up period.
Literatur
1.
Zurück zum Zitat Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg. 2007;204:580–7.CrossRefPubMed Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg. 2007;204:580–7.CrossRefPubMed
2.
Zurück zum Zitat Yamashita Y, Taketomi A, Itoh S, Kitagawa D, Kayashima H, Harimoto N, et al. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg. 2007;205:19–26.CrossRefPubMed Yamashita Y, Taketomi A, Itoh S, Kitagawa D, Kayashima H, Harimoto N, et al. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg. 2007;205:19–26.CrossRefPubMed
3.
Zurück zum Zitat Poon RTP, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10–24.CrossRef Poon RTP, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10–24.CrossRef
4.
Zurück zum Zitat Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10:1111–8.CrossRefPubMed Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10:1111–8.CrossRefPubMed
5.
Zurück zum Zitat Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg. 2006;244:265–73.CrossRefPubMed Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg. 2006;244:265–73.CrossRefPubMed
6.
Zurück zum Zitat Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191:381–8.CrossRefPubMed Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191:381–8.CrossRefPubMed
7.
Zurück zum Zitat Sakata J, Shirai Y, Wakai T, Kaneko K, Nagahashi M, Hatakeyama K. Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol. 2008;34:900–5.PubMed Sakata J, Shirai Y, Wakai T, Kaneko K, Nagahashi M, Hatakeyama K. Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol. 2008;34:900–5.PubMed
8.
Zurück zum Zitat Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101:796–802.CrossRefPubMed Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101:796–802.CrossRefPubMed
9.
Zurück zum Zitat Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B, et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology. 2002;49:41–6.PubMed Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B, et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology. 2002;49:41–6.PubMed
10.
Zurück zum Zitat Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, Wada H, et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery. 2007;141:196–202.CrossRefPubMed Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, Wada H, et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery. 2007;141:196–202.CrossRefPubMed
11.
Zurück zum Zitat Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg. 1998;227:80–5.CrossRefPubMed Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg. 1998;227:80–5.CrossRefPubMed
12.
Zurück zum Zitat Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol. 2007;14:2319–29.CrossRefPubMed Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol. 2007;14:2319–29.CrossRefPubMed
13.
Zurück zum Zitat Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation. 2009;87:531–7.CrossRefPubMed Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation. 2009;87:531–7.CrossRefPubMed
14.
Zurück zum Zitat Tanaka K, Shimada H, Matsuo K, Takeda K, Nagano Y, Togo S. Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection. World J Surg. 2008;32:1738–47.CrossRefPubMed Tanaka K, Shimada H, Matsuo K, Takeda K, Nagano Y, Togo S. Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection. World J Surg. 2008;32:1738–47.CrossRefPubMed
15.
Zurück zum Zitat Utsunomiya T, Shimada M, Shirabe K, Kajiyama K, Gion T, Takenaka K, et al. Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma. Hepatogastroenterology. 2001;48:1088–93.PubMed Utsunomiya T, Shimada M, Shirabe K, Kajiyama K, Gion T, Takenaka K, et al. Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma. Hepatogastroenterology. 2001;48:1088–93.PubMed
16.
Zurück zum Zitat Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996;131:71–6.PubMed Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996;131:71–6.PubMed
17.
Zurück zum Zitat Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991;214:114–7.CrossRefPubMed Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991;214:114–7.CrossRefPubMed
18.
Zurück zum Zitat Balsells J, Charco R, Lazaro JL, Murio E, Vargas V, Allende E, et al. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 1996;83:758–61.CrossRefPubMed Balsells J, Charco R, Lazaro JL, Murio E, Vargas V, Allende E, et al. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 1996;83:758–61.CrossRefPubMed
19.
Zurück zum Zitat Lo CM, Lai EC, Fan ST, Choi TK, Wong J. Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg. 1994;81:1019–21.CrossRefPubMed Lo CM, Lai EC, Fan ST, Choi TK, Wong J. Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg. 1994;81:1019–21.CrossRefPubMed
20.
Zurück zum Zitat Zhou XD, Yu YQ, Tang ZY, Yang BH, Lu JZ, Lin ZY, et al. Surgical treatment of recurrent hepatocellular carcinoma. Hepatogastroenterology. 1993;40:333–6.PubMed Zhou XD, Yu YQ, Tang ZY, Yang BH, Lu JZ, Lin ZY, et al. Surgical treatment of recurrent hepatocellular carcinoma. Hepatogastroenterology. 1993;40:333–6.PubMed
21.
Zurück zum Zitat Yoon KT, Kim JK, Kimdo Y, Ahn SH, Lee JD, Yun M, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology. 2007;72:104–110.CrossRefPubMed Yoon KT, Kim JK, Kimdo Y, Ahn SH, Lee JD, Yun M, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology. 2007;72:104–110.CrossRefPubMed
22.
Zurück zum Zitat Sun L, Guan YS, Pan WM, Chen GB, Luo ZM, Wu H. Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management. World J Gastroenterol. 2007;13:5413–5.PubMed Sun L, Guan YS, Pan WM, Chen GB, Luo ZM, Wu H. Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management. World J Gastroenterol. 2007;13:5413–5.PubMed
23.
Zurück zum Zitat Gion T, Taketomi A, Shimada M, Shirabe K, Hasegawa H, Takenaka K, et al. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma. Hepatology. 1998;28:1663–8.CrossRefPubMed Gion T, Taketomi A, Shimada M, Shirabe K, Hasegawa H, Takenaka K, et al. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma. Hepatology. 1998;28:1663–8.CrossRefPubMed
24.
Zurück zum Zitat Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375–82.CrossRefPubMed Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375–82.CrossRefPubMed
25.
Zurück zum Zitat Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, Dematteo RP, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249:617–23.CrossRefPubMed Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, Dematteo RP, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249:617–23.CrossRefPubMed
26.
Zurück zum Zitat Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235:217–25.CrossRefPubMed Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235:217–25.CrossRefPubMed
27.
Zurück zum Zitat Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg. 2006;93:1488–94.CrossRefPubMed Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg. 2006;93:1488–94.CrossRefPubMed
28.
Zurück zum Zitat Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327–48.CrossRefPubMed Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327–48.CrossRefPubMed
29.
Zurück zum Zitat Younes RN, Rogatko A, Vydelingum NA, Brennan MF. Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats. Surgery. 1991;109:307–12.PubMed Younes RN, Rogatko A, Vydelingum NA, Brennan MF. Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats. Surgery. 1991;109:307–12.PubMed
Metadaten
Titel
Predictors of Extrahepatic Recurrence After Curative Hepatectomy for Hepatocellular Carcinoma
verfasst von
Akinobu Taketomi, MD, PhD
Takeo Toshima, MD
Dai Kitagawa, MD, PhD
Takashi Motomura, MD
Kazuki Takeishi, MD
Yohei Mano, MD
Hiroto Kayashima, MD
Keishi Sugimachi, MD, PhD
Shinichi Aishima, MD, PhD
Yoichi Yamashita, MD, PhD
Toru Ikegami, MD, PhD
Tomonobu Gion, MD, PhD
Hideaki Uchiyama, MD, PhD
Yuji Soejima, MD, PhD
Takashi Maeda, MD, PhD
Ken Shirabe, MD, PhD
Yoshihiko Maehara, MD, PhD
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2010
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1076-2

Weitere Artikel der Ausgabe 10/2010

Annals of Surgical Oncology 10/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.